Dysregulation of TANK-binding kinase 1 (TBK1) homeostasis leads to the occurrence and progression of many diseases, such as inflammation, autoimmune diseases, metabolic diseases, and cancer. Therefore, there is a need to develop TBK1 inhibitors as therapeutic agents. In this review, we highlight the diverse biological functions of TBK1 and summarize the promising small-molecule inhibitors of TBK1 that have the potential to be developed as therapeutic candidates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.drudis.2021.05.016 | DOI Listing |
Publication Analysis
Top Keywords
tank-binding kinase
8
kinase tbk1
8
tbk1
5
tbk1 emerging
4
emerging therapeutic
4
therapeutic target
4
target drug
4
drug discovery
4
discovery dysregulation
4
dysregulation tank-binding
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!